Cargando…

The effects of ursodeoxycholic acid on sepsis-induced cholestasis management in an animal model

OBJECTIVES: Cholestasis refers to a reduction in bile flow from the liver into the biliary system. Ursodeoxycholic acid (UDCA) is commonly used for the treatment of hepatic cholestasis. This study aimed to explore the role of UDCA in the treatment and prevention of lipopolysaccharide (LPS)-induced c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ainosah, Randa H., Hagras, Magda M., Alharthi, Sameer E., Saadah, Omar I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taibah University 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479157/ https://www.ncbi.nlm.nih.gov/pubmed/32982635 http://dx.doi.org/10.1016/j.jtumed.2020.04.007

Ejemplares similares

Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit
por: Lewis, Tamorah, et al.
Publicado: (2018)

Ursodeoxycholic Acid and SMOFlipid for Treating Parenteral Nutrition Associated Cholestasis in Infants
por: Al-Alaiyan, Saleh, et al.
Publicado: (2022)

Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis
por: Gurung, Vinita, et al.
Publicado: (2009)

Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid
por: Joutsiniemi, Titta, et al.
Publicado: (2015)

Ursodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysis
por: Zhang, Yang, et al.
Publicado: (2016)

Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial
por: Fleminger, J, et al.
Publicado: (2020)

Effect of polyene phosphatidylcholine/ursodeoxycholic acid/ademetionine on pregnancy outcomes in intrahepatic cholestasis
por: Dong, Xiao-Rui, et al.
Publicado: (2023)

The Reversed Feto-Maternal Bile Acid Gradient in Intrahepatic Cholestasis of Pregnancy Is Corrected by Ursodeoxycholic Acid
por: Geenes, Victoria, et al.
Publicado: (2014)

Feto-Maternal Effects of Adding Rifampicin to Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy
por: Kumari, Anjali, et al.
Publicado: (2022)

Efficacy and safety of ursodeoxycholic acid in children with cholestasis: A systematic review and meta-analysis
por: Huang, Liang, et al.
Publicado: (2023)

Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis
por: Ovadia, Caroline, et al.
Publicado: (2021)

Paternal cholestasis exacerbates obesity-associated hypertension in male offspring but is prevented by paternal ursodeoxycholic acid treatment
por: Pataia, Vanessa, et al.
Publicado: (2018)

Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial
por: Chappell, Lucy C, et al.
Publicado: (2019)

Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis
por: Adeyemi, Oladipupo, et al.
Publicado: (2017)

Ursodeoxycholic acid use is associated with significant risk of morbidity and mortality in infants with cholestasis: A strobe compliant study
por: Kotb, Magd Ahmed, et al.
Publicado: (2020)

The Conservative Management of Choledocholithiasis With Ursodeoxycholic Acid
por: Oluboyede, Daniel O, et al.
Publicado: (2023)

Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial
por: Chappell, Lucy C, et al.
Publicado: (2012)

Influence of ursodeoxycholic acid therapy on levels of fibroblast growth factor 21, adiponectin and biochemical parameters in intrahepatic cholestasis of pregnancy
por: Kukla, Michał, et al.
Publicado: (2021)

Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study)
por: Kong, Xiang, et al.
Publicado: (2016)

CT Image Features under Reconstruction Algorithm in Analysis of the Effect of Probiotics Combined with Ursodeoxycholic Acid in Treatment of Intrahepatic Cholestasis of Pregnancy
por: Liu, Hongxue, et al.
Publicado: (2021)

Ursodeoxycholic acid improves pregnancy outcome in patients with intrahepatic cholestasis during pregnancy: A protocol for systematic review and meta-analysis
por: Wang, Yan, et al.
Publicado: (2021)

Ursodeoxycholate Restores Biliary Excretion of Methotrexate in Rats with Ethinyl Estradiol Induced-Cholestasis by Restoring Canalicular Mrp2 Expression
por: Kim, Min Ju, et al.
Publicado: (2018)

Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
por: Kotb, Magd A.
Publicado: (2012)

Pathophysiology of sepsis‐induced cholestasis: A review
por: Ghenu, Maria Iuliana, et al.
Publicado: (2022)

Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study
por: Manna, LB, et al.
Publicado: (2019)

High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy
por: Azzaroli, Francesco, et al.
Publicado: (2013)

Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study): Erratum
Publicado: (2017)

Biological synthesis of ursodeoxycholic acid
por: Song, Peng, et al.
Publicado: (2023)

Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
por: Tuncer, Ilyas, et al.
Publicado: (2012)

Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES)
por: Chappell, Lucy C., et al.
Publicado: (2018)

Cholestasis of Sepsis: A Case Report
por: Ghoda, Atit, et al.
Publicado: (2020)

Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin.
por: Choi, S. W., et al.
Publicado: (1991)

Ursodeoxycholic Acid Ameliorates Fructose-Induced Metabolic Syndrome in Rats
por: Mahmoud, Amr A. A., et al.
Publicado: (2014)

Ursodeoxycholic acid treatment in a rat model of cancer cachexia
por: Tschirner, Anika, et al.
Publicado: (2011)

Ursodeoxycholic Acid Halts Pathological Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy
por: Thounaojam, Menaka C., et al.
Publicado: (2020)

Ursodeoxycholic acid production by Gibberella zeae mutants
por: Kollerov, Vyacheslav, et al.
Publicado: (2022)

Ursodeoxycholic Acid Alters Bile Acid and Fatty Acid Profiles in a Mouse Model of Diet-Induced Obesity
por: Zhang, Yunjing, et al.
Publicado: (2019)

Ursodeoxycholic acid in the management of symptomatic gallstone disease: systematic review and clinician survey
por: Hall, Lewis, et al.
Publicado: (2023)

Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review
por: Li, Xuan, et al.
Publicado: (2020)

Predictive Model of Ursodeoxycholic Acid Treatment Response in Primary Biliary Cholangitis
por: Shu, Yanyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6phj6a9e7cdp04fagm8bjmf9hl